Patent · US Active

Compounds and compositions for use in treating psoriasis

US11179380B2 · kind B2 · utility

0Cited by

0References

16Claims

0Family size

Assignees

Solvotrin Therapeutics Limited · IE
THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, AND THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN · IE

Inventors

John Gilmer · Dublin, IE
Mark Ledwidge · Cork, IE
Pat O'Flynn · Cork, IE
Francis Quilty · Mullingar, IE
Kate O'Donnell · Ennistimon, IE

Key dates

Filing date	Mar 22, 2018
Grant date	Nov 23, 2021
Priority date	—
Expiry date	Mar 31, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P17/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds and pharmaceutical compositions for use in the treatment of psoriasis are disclosed. Preferred compounds have demonstrated efficacy in reducing skin scaling, erythema and skin thickness in the mouse model of Aldara-induced psoriasis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.